Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

NCT01590277 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

VA Office of Research and Development